Lymphoma Journal Impact Factor
The links below contain various information about Lymphoma Journal Impact Factor that might interest you. The links below contain various information about the keyword that might interest you. Review information from various sources to form a position based on as much information as possible.
· The 2016-2017 Journal Impact IF of Leukemia and Lymphoma is 2.755 Leukemia and Lymphoma Key Factor Analysis · The 2015-2016 Journal Impact IF of Leukemia and Lymphoma is 3.093 Leukemia and Lymphoma Key Factor Analysis
The Impact Factor of this journal is 3.231, ranking it 41 out of 76 in Hematology This journal is a part of Elsevier's Oncology Journal Network With this journal indexed in 12 international databases, your published article can be read and cited by researchers worldwide
The 2020-2021 Journal Impact IF of Clinical Lymphoma, Myeloma and Leukemia is 3.231, which is just updated in 2021. The highest Journal Impact IF of Clinical Lymphoma, Myeloma and Leukemia is 3.231. The lowest Journal Impact IF of Clinical Lymphoma, Myeloma and Leukemia is 1.667.
Leukemia & Lymphoma journal metrics Journal metrics Usage 343K annual downloads/views Citation metrics 3.280 (2020) Impact Factor 3.075 (2020) 5 year IF 4.1 (2020) CiteScore Q2 (2020) CiteScore Best Quartile 0.813 (2020) SNIP 0.961 (2020) SJR Speed/acceptance 21 days avg. from submission to first decision
The impact score (IS) 2020 of Leukemia and Lymphoma is 1.71, which is computed in 2021 as per its definition. Leukemia and Lymphoma IS is increased by a factor of 0.09 and approximate percentage change is 5.56% when compared to preceding year 2019, which shows a rising trend.
Lymphoma has ceased publication and is no longer accepting submissions. All previously published articles are available through the Table of Contents. The journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals. Go to Table of Contents.
Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management. Jorge J. Castillo, Brady E. Beltran, Luis Malpica, Mario L. Marques-Piubelli & Roberto N. Miranda. Pages: 2845-2853. Published online: 21 Jun 2021.
Ca-A Cancer Journal for Clinicians. journal. 62.937 Q1. 168 47 119. 3452. 15499 80 126.34. …
Annals of Lymphoma (AOL) is now a member of Committee on Publication Ethics (COPE) Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in …
We are sure that you have received all the information you are interested in about Lymphoma Journal Impact Factor. We recommend that you also look at data on similar issues related to journalism.